236. 偽性副甲状腺機能低下症 Pseudohypoparathyroidism Clinical trials / Disease details

臨床試験数 : 6 / 薬物数 : 4 - (DrugBank : 2) / 標的遺伝子数 : 20 - 標的パスウェイ数 : 28

1 trial found

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04240821 (ClinicalTrials.gov)	May 22, 2020	21/1/2020	Theophylline for Treatment of Pseudohypoparathyroidism	Open-Label Extension Study of Theophylline for Treatment of Pseudohypoparathyroidism	Pseudohypoparathyroidism;Pseudohypoparathyroidism Type 1a;Albright Hereditary Osteodystrophy	Drug: Theophylline ER	Ashley Shoemaker	NULL	Enrolling by invitation	2 Years	99 Years	All	34	Phase 2	United States

First Previous1Next Last